Who owns TherapeuticsMD, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TXMD from SEC Form 13F filings across 46 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 46 institutions disclosed 3.7M shares of TherapeuticsMD, Inc. worth $8.1M — about 31.7% of shares outstanding; the largest disclosed holder is Rubric Capital Management LP. Source: SEC Form 13F filings, parsed by EvidInvest.
46
13F holders
$8.1M
value, 2026 filers
31.7%
of shares outstanding (3.7M sh)
6
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TXMD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Rubric Capital Management LP | 1.2M | $2.6M | 0.0% | 10.3% | 0.0% |
| 2 | Clearline Capital LP | 635,222 | $1.4M | 0.1% | 5.5% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 353,697 | $781,670 | 0.0% | 3.1% | 0.0% |
| 4 | Tejara Capital Ltd | 344,482 | $761,305 | 0.3% | 3% | -0.4% |
| 5 | ADAR1 Capital Management, LLC | 342,447 | $756,808 | 0.0% | 3% | +63.7% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 146,599 | $323,984 | 0.0% | 1.3% | +0.3% |
| 7 | MORGAN STANLEY | 129,217 | $285,569 | 0.0% | 1.1% | 0.0% |
| 8 | BlackRock, Inc. | 115,145 | $254,470 | 0.0% | 1% | 0.0% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 105,849 | $233,989 | 0.0% | 0.9% | -3.6% |
| 10 | CITADEL ADVISORS LLC | 86,095 | $190,270 | 0.0% | 0.7% | +26.0% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 63,831 | $141,067 | 0.0% | 0.6% | 0.0% |
| 12 | STATE STREET CORP | 30,100 | $66,521 | 0.0% | 0.3% | 0.0% |
| 13 | XTX Topco Ltd | 21,246 | $46,954 | 0.0% | 0.2% | -22.7% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 19,719 | $43,579 | 0.0% | 0.2% | +84.2% |
| 15 | NORTHERN TRUST CORP | 18,556 | $41,009 | 0.0% | 0.2% | +15.3% |
| 16 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 17,000 | $37,570 | 0.0% | 0.1% | 0.0% |
| 17 | OSAIC HOLDINGS, INC. | 15,198 | $33,586 | 0.0% | 0.1% | +9833.3% |
| 18 | HRT FINANCIAL LPNEW | 14,727 | $32 | 0.0% | 0.1% | new |
| 19 | Vanguard Global Advisers, LLC | 4,937 | $10,911 | 0.0% | 0% | 0.0% |
| 20 | UBS Group AG | 4,660 | $10,299 | 0.0% | 0% | +1307.9% |
| 21 | Tower Research Capital LLC (TRC) | 1,582 | $3,496 | 0.0% | 0% | +4.8% |
| 22 | SBI Securities Co., Ltd. | 1,263 | $2,791 | 0.0% | 0% | +373.0% |
| 23 | ROYAL BANK OF CANADA | 833 | $1,000 | 0.0% | 0% | +338.4% |
| 24 | Smartleaf Asset Management LLC | 601 | $1,346 | 0.0% | 0% | 0.0% |
| 25 | JPMORGAN CHASE & CONEW | 293 | $657 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.